QA: Cartesian Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001453687_2026_Cartesian_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001453687, Cartesian Therapeutics Inc

  xvar xval
0 AssetsCurrent 129,276,000
1 IntangibleAssetsNetIncludingGoodwill 48,163,000
2 PropertyPlantAndEquipmentNet 12,185,000
3 remainder_Assets 106,787,000
4 LiabilitiesCurrent 14,937,000
5 LiabilitiesNoncurrent 8,525,000
6 remainder_Liabilities 399,189,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,317,735
9 ResearchAndDevelopmentExpense 59,909,473
10 remainder_Expenses 47,660,633
11 remainder_Revenues 4,999,061
12 remainder_NetIncome 2,947,401
13 remainder_ComprehensiveNetIncome 33,391
  yvar yval
0 Assets 296,411,000
1 Liabilities 422,651,000
2 Expenses 138,887,841
3 Revenues 4,999,061
4 StockholdersEquity -126,240,000
5 NetIncome -130,941,379
6 ComprehensiveNetIncome -130,924,684
7 BaseVar 432,964,847
8 EconomicCapitalRatiobeforeLimitedLiability -1.13
9 EconomicCapitalRatio 1.27

Edgar->Model Mapping

Feature Distribution

Change over Time